Newborn Asphyxia
7
5
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
29%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Cluster Randomized Controlled Trial Applying Helping Baby Breathe in Nepal
Cooling in Mild Encephalopathy
Advanced Wireless Sensors for Neonatal Care in the Delivery Room
Fetal Assessment of the Myocardium and Evaluation of the Neonate
Comparison of Visual Instructions for Inserting a Laryngeal Mask in a Neonatal Mannequin.
Is Feeding During Therapeutic Hypothermia Safe and Can Improve Outcomes in Infants With Hypoxic-ischaemic Encephalopathy
Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)